Andrew Hykes - Oct 29, 2024 Form 4 Insider Report for Inari Medical, Inc. (NARI)

Role
President and CEO, Director
Signature
/s/ Shannon Trevino, attorney-in-fact for Andrew Hykes
Stock symbol
NARI
Transactions as of
Oct 29, 2024
Transactions value $
-$150,000
Form type
4
Date filed
10/31/2024, 06:29 PM
Previous filing
Oct 3, 2024
Next filing
Nov 22, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NARI Common Stock Sale -$150K -3K -0.67% $50.00 445K Oct 29, 2024 Direct F1
holding NARI Common Stock 1.55K Oct 29, 2024 By Child 1
holding NARI Common Stock 1.55K Oct 29, 2024 By Child 2
holding NARI Common Stock 1.55K Oct 29, 2024 By Child 3
holding NARI Common Stock 1K Oct 29, 2024 By Spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023.